Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Sep;146(1):118-28.
doi: 10.1038/sj.bjp.0706304.

Electrophysiological and haemodynamic effects of endothelin ETA and ETB receptors in normal and ischaemic working rabbit hearts

Christopher McCabe  1 , Martin N Hicks, Kathleen A Kane, Cherry L Wainwright
Affiliations

Electrophysiological and haemodynamic effects of endothelin ETA and ETB receptors in normal and ischaemic working rabbit hearts

Christopher McCabe et al. Br J Pharmacol. 2005 Sep.

Abstract

The aims of this study were to determine if endothelin-1 (ET-1) under normal and ischaemic conditions exhibits a direct arrhythmogenic effect that is independent of its ability to cause coronary vasoconstriction, and to determine the contribution of the ET(A) and ET(B) receptor subtype. ET(A/B) (with ET-1) and ET(A) (ET-1 in the presence of BQ-788) receptor activation resulted in a significant reduction in both epi- and endocardial monophasic action potential duration (MAPD(90)). ET(A) receptor activation reduced both epi- and endocardial effective refractory period (ERP). This MAPD(90) and ERP shortening were associated with a reduction in coronary flow, myocardial contractility and induction of ventricular fibrillation (VF) during ERP measurement. The ET(B) agonist sarafotoxin (S6c) had no marked, or concentration-dependent, effect on MAPD(90), ERP, myocardial contractility or induction of arrhythmias. Neither ET-1 nor S6c, given prior to coronary artery occlusion, significantly changed the ischaemia-induced dispersion of MAPD(90), ERP or the % incidence of VF. In conclusion, neither ET(A) nor ET(B) receptor stimulation has a direct arrhythmogenic effect in isolated rabbit hearts under normal or ischaemic conditions. The ET-1-induced arrhythmogenic effect observed in nonischaemic hearts is likely to be the result of the associated coronary vasoconstriction caused by ET(A) receptor stimulation resulting in myocardial ischaemia.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Representative MAP recordings from the endocardium (top) and epicardium (bottom) before (baseline) and after 10−9 M ET-1 in an isolated working rabbit heart.
Figure 2
Figure 2
Effect of cumulative ET-1 (10−12–10−9 M) (top), ET-1 in the presence of BQ-788 (3 × 10−8 M) (middle) and S6c administration (10−12–10−8 M) (bottom) on LV epicardial and endocardial monophasic action potential duration (MAPD90) measured at 90% repolarisation (MAPD90, ms) in isolated working rabbit hearts. Dashed line indicates solution change. *P<0.05 compared to baseline (15 min) values. n=6, unless otherwise stated.
Figure 3
Figure 3
Effect of cumulative ET-1 (10−12–10−9 M) (top), ET-1 in the presence of BQ-788 (3 × 10−8 M) (middle) and S6c administration (10−12–10−8 M) (bottom) on LV epicardial and endocardial ERP (ERP, ms) in isolated working rabbit hearts. Dashed line indicates solution change. *P<0.05 compared to baseline (15 min) values. n=6, unless otherwise stated.
Figure 4
Figure 4
Effect of cumulative ET-1 (10−12–10−9 M), ET-1 (10−12–10−9 M) in the presence of BQ-788 (3 × 10−8 M) and S6c (10−12–10−8 M) administration on coronary flow in isolated working rabbit hearts. Dashed line indicates solution change. *P<0.05 compared to baseline (15 min) values. n=6, unless otherwise stated.
Figure 5
Figure 5
Change in MAPD90 in the epicardium (AAR) (top) and endocardium (bottom) of working rabbit hearts treated with 10−10 M ET-1 or vehicle before and during acute regional ischaemia and reperfusion. *Significantly different from predrug value. **Statistically significant differences from respective preischaemic values (P<0.05 in each case) (n=6–12).
Figure 6
Figure 6
Change in MAPD90 in the epicardium (AAR) (top) and endocardium (bottom) of working rabbit hearts treated with 10−8 M S6c or vehicle before and during acute regional ischaemia and reperfusion. **Statistically significant differences from respective preischaemic values (P<0.05 in each case) (n=6–12).
Figure 7
Figure 7
Coronary flow in working rabbit hearts treated with vehicle, 10−10 M ET-1 (top) or S6c (10−8 M) (bottom) before and during acute regional ischaemia and reperfusion. #Statistically significant difference from control ligation values. **Statistically significant difference from respective preischaemic values (P<0.05 in each case) (n=6–12).
See this image and copyright information in PMC

References

    1. BECKER R., MERKELY B., BAUER A., GELLER L., FAZEKAS L., FREIGANG K.D., VOSS F., SENGES J.C., KUEBLER W., SCHOELS W. Ventricular arrhythmias induced by endothelin-1 or by acute ischaemia: a comparative analysis using three-dimensional mapping. Cardiovasc. Res. 2000;45:310–320. - PubMed
    1. BEYER M.E., HOVELBORN T., DELEBAR U., HOFFMEISTER H.M. Significance of the endothelin A receptor for the haemodynamic and inotropic effects of endothelin-1 in rats. Clin. Sci. 2004;107:467–475. - PubMed
    1. CROCKETT T.R., SHARIF I., KANE K.A., WAINWRIGHT C.L. Sarafotoxin 6c (S6c) protects against ischaemia-induced cardiac arrhythmias in vivo and in vitro in the rat. J. Cardiovasc. Pharmacol. 2000;36 Suppl 1:S297–S299. - PubMed
    1. DOWNAR E., JANSE M.J., DURRER D. The effect of ‘ischemic' blood on transmembrane potentials of normal porcine ventricular myocardium. Circulation. 1977;55:455–462. - PubMed
    1. DURU F., BARTON M., LUSCHER T.F., CANDINAS R. Endothelin and cardiac arrhythmias: do endothelin antagonists have a therapeutic potential as antiarrhythmic drugs. Cardiovasc. Res. 2001;49:272–280. - PubMed

Publication types

MeSH terms